Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 212265/Z/18/Z
Wellcome Centre for Infectious Diseases Research
Grant: 203135/Z/16/Z
Black Academic Advancement Programme
Grant: UID120647
National Research Foundation
Grant: UID113983
National Research Foundation
Grant: 119078
NIH
Grant: AI077505
NIH
Grant: AI110527
NIH
Grant: TR000445
Wellcome Trust
Grant: 212265
Critical questions for dolutegravir-based ART in Africa
NIAID NIH HHS
Grant: P30 AI110527
NIAID NIH HHS
Grant: R01 AI077505
NCATS NIH HHS
Grant: UL1 TR000445
Wellcome Trust
Grant: 203135
Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
National Institutes of Health
Grant: 5P30AI110527-04
Tennessee Center for AIDS Research (TN-CFAR)
South African Medical Research Council
Pharmacometrics Africa NPC
Unitaid and ViiVHealthcare
ViiVHealthcare and Gilead Sciences
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals